![Troy Ignelzi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Troy Ignelzi
Directeur Financier/CFO chez
RAPPORT THERAPEUTICS, INC.
Fortune : 416 700 $ au 30/06/2026
Profil
Troy A. Ignelzi is currently Chairman at Vedanta Biosciences, Inc. since 2020.
He is an Independent Director at Abivax SA starting in 2023, at Contineum Therapeutics, Inc. starting in 2024, and at Harmony Biosciences Holdings, Inc. starting in 2026.
He is also Chief Financial Officer at Rapport Therapeutics, Inc. since 2023.
Formerly, Mr. Ignelzi was Independent Director at CinCor Pharma, Inc. from 2021 to 2023.
He served as Chief Financial Officer at Karuna Therapeutics, Inc. from 2019 to 2023 and as Chief Financial & Accounting Officer at scPharmaceuticals, Inc. from 2016 to 2019.
He was Chief Financial Officer at Juventas Therapeutics, Inc. from 2014 to 2016.
He held the position of Senior VP-Operations & Business Development at PharmaLex GmbH from 2013 to 2014.
He was Vice President-Business Development at Esperion Therapeutics, Inc. from 2009 to 2013 and VP-Business Development & Strategic Planning at InSys Therapeutics, Inc. from 2007 to 2009.
Mr. Ignelzi completed undergraduate studies at Ferris State University (Michigan).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/04/2026 | 10 000 ( 0,02 % ) | 416 700 $ | 30/06/2026 | |
| 26/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
| 02/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
ABIVAX SA -.--% | 28/02/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Troy Ignelzi
| Sociétés | Poste | Début |
|---|---|---|
| ABIVAX | Directeur/Membre du Conseil | 11/07/2023 |
| RAPPORT THERAPEUTICS, INC. | Directeur Financier/CFO | 01/11/2023 |
| CONTINEUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/05/2024 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Directeur/Membre du Conseil | 02/04/2026 |
Anciens postes connus de Troy Ignelzi
| Sociétés | Poste | Fin |
|---|---|---|
| KARA THER | Directeur Financier/CFO | 29/09/2023 |
| CINCOR PHARMA, INC. | Directeur/Membre du Conseil | 24/02/2023 |
| SCPHARMACEUTICALS INC. | Directeur Financier/CFO | 28/02/2019 |
Juventas Therapeutics, Inc.
 Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Directeur Financier/CFO | 01/02/2016 |
PharmaLex GmbH
 PharmaLex GmbH Packaged SoftwareTechnology Services Develops AI and machine learning automation for pharmacy, biotech & med tech industries | Directeur des opérations | 01/10/2014 |
Formation de Troy Ignelzi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Ferris State University (Michigan)
 Ferris State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InSys Therapeutics, Inc. /Old/
 InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products | Health Technology |
Juventas Therapeutics, Inc.
Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Health Services |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
PharmaLex GmbH
PharmaLex GmbH Packaged SoftwareTechnology Services Develops AI and machine learning automation for pharmacy, biotech & med tech industries | Technology Services |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
